Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 4/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | HPGD | P15428 | 3/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 3/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | HTT | P42858 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.33 |
| ▸ | FYN | P06241 | 1/20 | 0.33 |
| ▸ | MAOA | P21397 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | AHR | P35869 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | NCF1 | P14598 | 1/20 | 0.31 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.31 |
| ▸ | MAT2A | P31153 | 1/20 | 0.30 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10015399 | 0.85 | CRHR1 (0.35) | CYP1A2HSD17B10ALDH1A1HPGDLMNA | |
| SCHEMBL503375 | 0.83 | CYP1A2 (0.44) | CYP1A2HSD17B10ALDH1A1HPGDTHRB | |
| SCHEMBL14700561 | 0.82 | CRHR1 (0.32) | — | |
| SCHEMBL13101555 | 0.81 | CYP1A2 (0.39) | CYP1A2HSD17B10ALDH1A1HPGDTHRB | |
| SCHEMBL23348932 | 0.79 | CYP1A2 (0.37) | CYP1A2HSD17B10ALDH1A1HPGDTHRB | |
| SCHEMBL13101553 | 0.78 | CYP11B1 (0.49) | CYP1A2HSD17B10ALDH1A1HPGDTHRB | |
| SCHEMBL13090464 | 0.77 | ALDH1A1 (0.38) | CYP1A2HSD17B10ALDH1A1HPGDTHRB | |
| SCHEMBL17119049 | 0.76 | CA1 (0.38) | CYP1A2HSD17B10ALDH1A1HPGDTHRB | |
| SCHEMBL7128292 | 0.76 | ALDH1A1 (0.64) | CYP1A2HSD17B10ALDH1A1HPGDTHRB | |
| SCHEMBL22916881 | 0.75 | CYP1A2 (0.39) | CYP1A2HSD17B10ALDH1A1HPGDTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190245152-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2019-08-08 | — | — | US | disclosed |
| US-8293384-B2 | Organic compound, light-emitting device, and image display apparatus | CANON KABUSHIKI KAISHA (JP) | 2012-10-23 | — | — | US | disclosed |
| US-8293384-B2 | Organic compound, light-emitting device, and image display apparatus | CANON KABUSHIKI KAISHA (JP) | 2012-10-23 | — | — | US | disclosed |
| US-20100270914-A1 | NOVEL ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, AND IMAGE DISPLAY APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2010-10-28 | — | — | US | disclosed |
| US-20100270914-A1 | NOVEL ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, AND IMAGE DISPLAY APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2010-10-28 | — | — | US | disclosed |
| EP-2243761-A1 | Phenanthrene derivatives, light-emitting device and image display apparatus using the same | Canon Kabushiki Kaisha (JP) | 2010-10-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100270914-A1 | NOVEL ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, AND IMAGE DISPLAY APPARATUS | ACE2, ACE, AGTR1 | CYP1A2 50/4885HSD17B10 475/4885ALDH1A1 100/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.